In an exploration of 2 distinct timeframes in the 21st century, researchers examine the use and concurrent use of medication types among elderly US adults.
|Articles|September 19, 2007
NACDS: Delay implementation of tamper-resistant paper
NACDS urges delay of tamper-resistant paper implementation deadlines
Advertisement
NACDS has collaborated with more than 45 national, state, local, and other health organizations to strongly urge members of the Senate Finance Committee and the House Committee on Energy and Commerce to delay a provision included in an Iraq War Supplemental Appropriations bill. This provision requires all Medicaid prescriptions to be written on "tamper-resistant" Rx paper in order to be eligible for federal reimbursement beginning Oct. 1. NACDS is calling for a one-year delay to allow for sufficient time for uniform compliance.
To go to the Drug Topics homepage,
Advertisement
Related to this article
The investigational anti–IL-33 antibody lowered exacerbation rates across all blood eosinophil levels, a benefit current COPD biologics do not offer.
This episode offers a detailed look into the FDA’s recent PCAC meeting and what the future of peptide compounding could lead to for pharmacy professionals.
A study finds children starting continuous glucose monitoring within a month of diagnosis sustained lower hemoglobin A1C than those who started later.
With obesity, muscle loss, and sleep disorders so prominent in postmenopause, providers are now looking into further expansion of GLP-1 use.
Menopause status and symptoms are inconsistently captured in electronic health records, leaving a gap in care for patients.
As midterm elections approach, the pharmacy industry is backing one of its most meaningful bills yet while the current congressional session wanes.
Data found reduced cardiovascular risk with hormone therapy, particularly among Black women and those starting treatment within 10 years of menopause.
Advertisement
Advertisement
Trending on Drug Topics
1
Tozorakimab Reduces COPD Exacerbations in Phase 3 Trials
2
Muscle Preservation Is Key in GLP-1 Therapy for Postmenopausal Women
3
Injectable HIV Treatment Beats Daily Pills in Adolescent Trial
4
FDA Approves Onswik Weekly Insulin for Adults With T2D
5